BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22256965)

  • 1. Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs.
    Ceperuelo-Mallafré V; Escoté X; Viladés C; Peraire J; Domingo P; Solano E; Sirvent JJ; Pastor R; Tinahones F; Leal M; Richart C; Vendrell J; Vidal F; ; Alba V; Aguilar A; Auguet T; Chacón MR; López-Dupla M; Megia A; Miranda M; Olona M; Saurí A; Vargas M; Velasco I; Veloso S; Fontanet A; Gutiérrez M; Mateo G; Muñoz J; Sambeat MA
    HIV Med; 2012 May; 13(5):297-303. PubMed ID: 22256965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy.
    Veloso S; Escoté X; Ceperuelo-Mallafré V; López-Dupla M; Peraire J; Viladés C; Domingo P; Castro A; Olona M; Sirvent JJ; Leal M; Vendrell J; Richart C; Vidal F
    Cytokine; 2012 May; 58(2):253-60. PubMed ID: 22364914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
    Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
    Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocyte-derived hormone levels in HIV lipodystrophy.
    Kosmiski L; Kuritzkes D; Lichtenstein K; Eckel R
    Antivir Ther; 2003 Feb; 8(1):9-15. PubMed ID: 12713059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of fatty acid binding protein 4 in HIV-1 infection and in combination antiretroviral therapy-related metabolic disturbances and lipodystrophy.
    Escoté X; Megia A; López-Dupla M; Miranda M; Veloso S; Alba V; Domingo P; Pardo P; Viladés C; Peraire J; Giralt M; Richart C; Vendrell J; Vidal F;
    HIV Med; 2011 Aug; 12(7):428-37. PubMed ID: 21251185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy.
    Estrada V; Martínez-Larrad MT; González-Sánchez JL; de Villar NG; Zabena C; Fernández C; Serrano-Ríos M
    Metabolism; 2006 Jul; 55(7):940-5. PubMed ID: 16784968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc-α2-glycoprotein: is there association between this new adipokine and body composition in hemodialysis patients?
    Leal VO; Lobo JC; Stockler-Pinto MB; Farage NE; Velarde GC; Fouque D; Leite M; Mafra D
    Ren Fail; 2012; 34(9):1062-7. PubMed ID: 22906217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy.
    Bard JM; Lassalle R; Capeau J; Bach-Ngohou K; Nazih-Sanderson F; Rémy G; Reynes J; Ecobichon JL; Savès M; Raffi F;
    Antivir Ther; 2006; 11(3):361-70. PubMed ID: 16759053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.
    Redgrave BE; Stone SF; French MA; Krueger R; James IR; Price P
    HIV Med; 2005 Sep; 6(5):307-12. PubMed ID: 16156877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy.
    Shah M; Tierney K; Adams-Huet B; Boonyavarakul A; Jacob K; Quittner C; Dinges W; Peterson D; Garg A
    HIV Med; 2005 Jul; 6(4):291-8. PubMed ID: 16011535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma zinc α2-glycoprotein levels are elevated in smokers and correlated with metabolic syndrome.
    Tsai JS; Chen SC; Huang KC; Lue BH; Lee LT; Chiu TY; Chen CY; Guo FR; Chuang LM
    Eur J Clin Invest; 2015 May; 45(5):452-9. PubMed ID: 25708842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls.
    Bergersen BM; Schumacher A; Sandvik L; Bruun JN; Birkeland K
    Scand J Infect Dis; 2006; 38(8):682-9. PubMed ID: 16857615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Lee HC; Kim JM
    Metabolism; 2009 Nov; 58(11):1523-9. PubMed ID: 19501863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.
    Escoté X; Aranda GB; Mora M; Casals G; Enseñat J; Vidal O; Esteban Y; Halperin I; Hanzu FA
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):26-33. PubMed ID: 28440767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
    Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD
    Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy.
    Andersen O; Eugen-Olsen J; Kofoed K; Iversen J; Haugaard SB
    J Med Virol; 2008 Feb; 80(2):209-16. PubMed ID: 18098145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors.
    Temple ME; Koranyi KI; Nahata MC
    Ann Pharmacother; 2003 Sep; 37(9):1214-8. PubMed ID: 12921501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases].
    Tao MM; Zhang L; Qiu ZF; Xie J; Han Y; Yu W; Li M; Li TS
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):867-71. PubMed ID: 19671283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.